8-55773683-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_024831.8(TGS1):c.65G>T(p.Cys22Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000385 in 1,611,610 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_024831.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TGS1 | NM_024831.8 | c.65G>T | p.Cys22Phe | missense_variant | 1/13 | ENST00000260129.6 | NP_079107.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TGS1 | ENST00000260129.6 | c.65G>T | p.Cys22Phe | missense_variant | 1/13 | 1 | NM_024831.8 | ENSP00000260129.5 | ||
TGS1 | ENST00000523948.5 | n.65G>T | non_coding_transcript_exon_variant | 1/11 | 1 | ENSP00000430467.1 |
Frequencies
GnomAD3 genomes AF: 0.0000985 AC: 15AN: 152264Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000403 AC: 10AN: 248412Hom.: 0 AF XY: 0.0000223 AC XY: 3AN XY: 134310
GnomAD4 exome AF: 0.0000322 AC: 47AN: 1459346Hom.: 0 Cov.: 32 AF XY: 0.0000289 AC XY: 21AN XY: 725942
GnomAD4 genome AF: 0.0000985 AC: 15AN: 152264Hom.: 0 Cov.: 33 AF XY: 0.000121 AC XY: 9AN XY: 74402
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 21, 2024 | The c.65G>T (p.C22F) alteration is located in exon 1 (coding exon 1) of the TGS1 gene. This alteration results from a G to T substitution at nucleotide position 65, causing the cysteine (C) at amino acid position 22 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at